Publication:

Pseudomonas Aeruginosa Inducing Nociception Increases Susceptibility to Bacterial Keratitis

Loading...
Thumbnail Image

Date

2019-02-07

Published Version

Published Version

Journal Title

Journal ISSN

Volume Title

Publisher

The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Lin, Tiffany. 2019. Pseudomonas Aeruginosa Inducing Nociception Increases Susceptibility to Bacterial Keratitis. Master's thesis, Harvard Extension School.

Abstract

Understanding nociceptive signaling during Pseudomonas keratitis and its impact on the immune response can prove to be useful for this very painful infection. While the cornea is one of the mostly densely innervated organs in the body, the role that nociception has during bacterial keratitis has yet to be elucidated. In this study, I utilize a novel experimental mouse model, using systemic treatment of Resiniferatoxin (RTX), a potent capsaicin analog that ablates TRPV1 positive neurons to assess the role of sensory neurons during Pseudomonas keratitis. While this model has been used to study lung, skin and gut pathologies, it has yet be confirmed whether this would prove to be useful in the context of the eye. Treated mice were used for an in vivo bacterial keratitis experiment to assess the impact that sensory neurons have on bacterial clearance and inflammation. Using in vitro experiments such as calcium imaging of primary trigeminal ganglia neurons, I assessed whether the pathogen can directly activate neurons depending on virulence factors. My results demonstrate that nociceptors can be directly activated by Pseudomonas and mediate immune response to infection. This could be due to CGRP, where we found that the presence of the neuropeptide impeded neutrophil dependent bacterial killing and reduced bacterial clearance in mice.

Description

Other Available Sources

Research Data

Keywords

nociception, TRPV1, CGRP Pseudmonas aeruginosa, Type IV pili, neutrophils

Terms of Use

This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service

Endorsement

Review

Supplemented By

Related Stories